MUNICH - Dr. Kristian Schleede, a member of the supervisory body at Mutares (ETR:MUXG) SE & Co. KGaA, has exercised options under the company's Stock Option Plan 2016, leading to an off-market acquisition of shares totaling 306,500 euros. The transaction involved the purchase of 25,000 shares at a price of 12.26 euros each, executed outside of trading venues.
Details of the transaction, which took place at the Munich-based headquarters at Arnulfstr.19, were disclosed in a financial statement revealing that the shares acquired carry the ISIN DE000A2NB650. This strategic move by Dr. Schleede aligns with his role within the company and represents a significant investment in Mutares SE & Co. KGaA's future.
The stock option exercise and subsequent share acquisition underscore the confidence that key insiders have in the company's prospects. The transaction, finalized on Thursday last week, reflects a substantial commitment by Dr. Schleede to the firm's ongoing success and growth strategy.
Mutares SE & Co. KGaA specializes in acquiring and actively developing companies within Europe in sectors such as automotive & mobility, engineering & technology, goods & services, and construction & infrastructure with the aim of increasing their value through operational improvements and strategic repositioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.